Cardiac pacing for prevention of recurrent vasovagal syncope

Annals of Internal Medicine

Volumn 122, Issue 3, 1995, Pages 204-209

  Benditt, David G ^a   Petersen, Mark ^b   Lurie, Keith G ^a   Grubb, Blair P ^c   Sutton, Richard ^d  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EXAMINATION; FOLLOW UP; HEART PACING; HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; STATISTICAL ANALYSIS; SYNCOPE; TILTING;

EID: 0028870290     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-122-3-199502010-00008     Document Type: Review

References (47)

1. Dermksian G, Lamb LE. Syncope in a population of healthy young adults. JAMA. 1958;168:1200-7.
2. Wayne HH. Syncope: physiological considerations and an analysis of the clinical characteristics in 510 patients. Am J Med. 1961;30:418-38.
3. Day SC, Cook EF, Funkenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med. 1982;73:15-23.
4. Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA. Epidemiologic features of isolated syncope: the Framingham Study. Stroke. 1985;16:626-9.
5. Ross RT. Syncope. Philadelphia: W.B. Saunders; 1988.
6. Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore). 1990;69:160-75.
7. Benditt DG, Sakaguchi S, Schultz JJ, Remole S, Adler S, Lurie KG. Syncope. Diagnostic considerations and the role of tilt table testing. Cardiol Rev. 1993;1:146-56.
8. Calkins H, Byrne M, el-Atassi R, Kalbfleisch S, Langberg JJ, Morady F. The economic burden of unrecognized vasodepressor syncope. Am J Med. 1993;95:473-9.
9. Almquist A, Goldenberg IF, Milstein S, Chen MY, Chen XC, Hansen R, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 1989;320:346-51.
10. Sra JS, Murthy VS, Jazayeri MR, Shen YH, Troup PJ, Avitall B, et al. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol. 1993;19:402-8.
11. Milstein S, Buetikofer J, Dunnigan A, Benditt DG, Gornick C, Reyes WJ. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol. 1990;65:1339-44.
12. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol. 1992;70:339-42.
13. Fitzpatrick A, Williams T, Ahmed R, Lightman S, Bloom SR, Sutton R. Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. European Journal of Cardiac Pacing and Electrophysiology. 1992;2:121-8.
14. Kosinski DJ, Grubb BP, Temesy-Armos PN. The use of serotonin re-uptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res. 1994;1:85-90.
15. Raviele A, Gasparini G, Di Pede F, Delise P, Bonso A, Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol. 1990;65:1322-7.
16. Benditt DG, Remole S, Bailin S, Dunnigan A, Asso A, Milstein S. Tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope: rationale and proposed protocols. PACE Pacing Clin Electrophysiol. 1991;14:1528-37.
17. Dreifus LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet V. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). J Am Coll Cardiol. 1991;18:1-13.
18. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. European Journal of Cardiac Pacing and Electrophysiology. 1992;2:180-3.
19. de Mey C, Enterling D. Variant responses impair the usefulness of passive upright tilt in drug research. Methods Find Exp Clin Pharmacol. 1988:10;57-64.
20. Chen XC, Chen MY, Remole S, Kobayashi Y, Dunnigan A, Milstein S, et al. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol. 1992;69:755-60.
21. Fish FA, Strasburger JF, Benson DW Jr. Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope. Am J Cardiol. 1992:70;605-9.
22. Grubb BP, Wolfe D, Temesy-Armos P, Hahn H, Elliott L. Reproducibility of head upright tilt table test results in patients with syncope. PACE Pacing Clin Electrophysiol. 1992:15;1477-81.
23. Chen MY, Goldenberg IF, Milstein S, Buetikofer J, Almquist A, Lesser J, et al. Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope. Am J Cardiol. 1989;63:66-72.
24. Blanc JJ, Genet L, Mansourati J, Forneiro I, Corbel C, Pennec Y, et al. Interet du test d'inclinaison dans le diagnostic etiologique des pertes de connaissance [Value of the head-up tilt test in the etiologic diagnosis of syncope]. Presse Med. 1990;19:857-9.
25. Pongiglione G, Fish FA, Strasburger JF, Benson DW Jr. Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope. J Am Coll Cardiol. 1990;16:165-70.
26. Weiss S, Baker JP. The carotid sinus reflex in health and disease. Its role in the causation of fainting and convulsions. Medicine. 1933;12: 297-354.
27. Almquist A, Gornick C, Benson W Jr, Dunnigan A, Benditt DG. Carotid sinus hypersensitivity: evaluation of the vasodepressor component. Circulation. 1985;71:927-36.
28. Chosy JJ, Graham DT. Catecholamines in vasovagal fainting. J Psychosom Res. 1965;9:189-94.
29. Vingerhoets AJ. Biochemical changes in two subjects succumbing to syncope. Psychosom Med. 1984;46:95-103.
30. de Mey C, Enterling D. Assessment of the hemodynamic response to single passive head up tilt by non-invasive methods in normotensive subjects. Methods Find Exp Clin Pharmacol. 1986;8:449-57.
31. Fitzpatrick A, Theodorakis G, Vardas P, Kenny RA, Travill CM, Ingram A, et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J. 1991;12:389-94.
32. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 1991;17:125-30.
33. Vardas P, Vemmos C, Vrouchos G, Moulopoulos S. The tilting test in asymptomatic individuals with severe and unexplained sinus bradycardia [Abstract]. Revue Europeenne Technologie Biomedicale. 1990;12: 910.
34. Sheldon R, Splawinski J, Killam S. Reproducibility of isoproterenol tilt-table tests in patients with syncope. Am J Cardiol. 1992;69:1300-5.
35. Newman D, Lurie K, Roseqvist M, Washington C, Schwartz J, Scheinman MM. Head-up tilt testing with and without isoproterenol infusion in healthy subjects of different ages. PACE Pacing Clin Electrophysiol. 1993;16:715-21.
36. de Buitleir M, Grogan EW Jr, Picone MF, Casteen JA. Immediate reproducibility of the tilt-table test in adults with unexplained syncope. Am J Cardiol. 1993;71:304-7.
37. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med. 1992;116:358-63.
38. Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA. Prospective evaluation of day-to-day reproducibility of tilt-table testing in unexplained syncope. Am J Cardiol. 1993;71:1289-92.
39. MacWilliam JA. Electric stimulation of the mammalian heart. J Internat M Congr. 1887;3:253-255.
40. Sapire DW, Casta A, Safley W, O'Riordan AC, Balsara RK. Vasovagal syncope in children requiring pacemaker implantation. Am Heart J. 1983:106;1406-11.
41. Kus T, Lalonde G, de Champlain J, Shenasa M. Vasovagal syncope: management with atrioventricular sequential pacing and beta-blockade. Can J Cardiol. 1989:5;375-8.
42. Perry JC, Friedman RA, Moak JP, Garson A Jr. Bradycardia and syncope in children not controlled by pacing: beta-adrenergic hypersensitivity. PACE Pacing Clin Electrophysiol. 1991:14;391-4.
43. Fitzpatrick AP, Travill CM, Vardas PE, Hubbard WN, Wood A, Ingram A, et al. Recurrent symptoms after ventricular pacing in unexplained syncope. PACE Pacing Clin Electrophysiol. 1990;13:619-24.
44. Fitzpatrick A, Theodorakis G, Ahmed R, Williams T, Sutton R. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degrees tilt. PACE Pacing Clin Electrophysiol. 1991;14:13-9.
45. Samoil D, Grubb BP, Brewster P, Moore J, Temesy-Armos P. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol. 1993;1:36-41.
46. Sra JS, Jazayeri MR, Avitall B, Dbala A, Deshpande S, Blanck Z, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med. 1993;328:1085-90.
47. Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J. 1994;71:274-81.